NEW YORK (dpa-AFX Broker) - The US bank JPMorgan has raised its price target for Carl Zeiss Med itec from 52 to 59 euros after the figures for the first quarter, but left the rating at "Underweight". The manufacturer of medical technology devices was more profitable than expected, wrote analyst Anchal Verma in a study published on Monday. However, profitability in the second quarter is likely to decline again compared to the first quarter./bek/edh
Publication of the original study: 09.02.2024 / 19:10 / GMT
First dissemination of the original study: 12/02/2024 / 00:15 / GMT
-----------------------
dpa-AFX Broker - the Trader News from dpa-AFX
-----------------------